PHGDH
PHGDH (phosphoglycerate dehydrogenase, also known as SERA, PGDH and PDG) is an NAD-dependent oxidoreductase that catalyses the first step of phosphorylated L-serine biosynthesis. It belongs to the D-isomer specific 2-hydroxyacid dehydrogenase family. Browse Assay Genie's current range of PHGDH research reagents below, or read on for the biology behind the target.
PHGDH catalyses the reversible oxidation of 3-phospho-D-glycerate to 3-phosphonooxypyruvate. This is the first step of the phosphorylated L-serine biosynthesis pathway. The enzyme also catalyses the reversible oxidation of 2-hydroxyglutarate to 2-oxoglutarate, and the reversible oxidation of (S)-malate to oxaloacetate. It requires NAD/NADH as a cofactor and forms homotetramers for activity.
The PHGDH gene encodes the enzyme involved in the early steps of L-serine synthesis in animal cells. L-serine is required for the synthesis of D-serine and other amino acids, which places PHGDH at the entry point of a pathway that supplies several downstream products. The protein is a member of the D-isomer specific 2-hydroxyacid dehydrogenase family, and its HGNC gene group is oxidoreductases. Mouse and rat orthologs, both named Phgdh, are recognised.
Mutations in the PHGDH gene have been found in a family with congenital microcephaly, psychomotor retardation and other symptoms. Multiple alternatively spliced transcript variants have been reported, although the full-length nature of most is not known. Researchers studying serine metabolism, 2-hydroxyglutarate turnover or the biology of this enzyme often work with PHGDH antibody, PHGDH ELISA kit and PHGDH protein reagents to measure expression and activity.
PHGDH catalyses the first step of the phosphorylated L-serine pathway, making it a central enzyme for studying how animal cells synthesise serine.
L-serine is required for D-serine and other amino acid synthesis, so PHGDH is relevant to wider amino acid metabolic studies.
PHGDH oxidises 3-phospho-D-glycerate, 2-hydroxyglutarate and (S)-malate using NAD/NADH, and acts as a homotetramer, offering a model for dehydrogenase mechanisms.
Mutations in the PHGDH gene have been found in a family with congenital microcephaly and psychomotor retardation, linking the enzyme to neurological disease research.
PHGDH catalyses the reversible oxidation of 3-phospho-D-glycerate to 3-phosphonooxypyruvate, the first step of phosphorylated L-serine biosynthesis. It also oxidises 2-hydroxyglutarate to 2-oxoglutarate and (S)-malate to oxaloacetate. The enzyme uses NAD/NADH as a cofactor and is active as a homotetramer.
PHGDH stands for phosphoglycerate dehydrogenase, and UniProt names the protein D-3-phosphoglycerate dehydrogenase. Aliases include SERA, PGDH and PDG. Its EC number is 1.1.1.95. Multiple alternatively spliced transcript variants have been described, though the full-length nature of most is not known.
Mouse and rat both have a Phgdh ortholog, and the enzyme is involved in L-serine synthesis in animal cells. Mutations in the human gene have been found in a family with congenital microcephaly, psychomotor retardation and other symptoms. Check the datasheet of any product for its validated reactivity.
Other serine-pathway enzymes, dehydrogenases and metabolic targets with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt O43175; product specifications from Assay Genie datasheets.